Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.117
+0.024 (26.33%)
Nov 21, 2024, 12:54 PM EST - Market open
Conduit Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.73 | 5.17 | 3.05 | 2.89 |
| Research & Development | 3.34 | 0.09 | 0.04 | 0.03 |
| Operating Expenses | 13.07 | 5.26 | 3.09 | 2.92 |
| Operating Income | -13.07 | -5.26 | -3.09 | -2.92 |
| Interest Expense | -0.81 | -0.21 | - | - |
| Interest & Investment Income | 0.03 | 0.02 | - | - |
| Currency Exchange Gain (Loss) | -0.25 | -0.36 | - | -0.01 |
| Other Non Operating Income (Expenses) | 0.61 | 5.29 | -1.67 | -0.66 |
| EBT Excluding Unusual Items | -13.49 | -0.54 | -4.76 | -3.58 |
| Gain (Loss) on Sale of Investments | - | - | -0.13 | -0.08 |
| Pretax Income | -15.15 | -0.54 | -4.89 | -3.66 |
| Net Income | -15.15 | -0.54 | -4.89 | -3.66 |
| Net Income to Common | -15.15 | -0.54 | -4.89 | -3.66 |
| Shares Outstanding (Basic) | 77 | 67 | 37 | - |
| Shares Outstanding (Diluted) | 77 | 68 | 37 | - |
| Shares Change (YoY) | 24.50% | 81.30% | - | - |
| EPS (Basic) | -0.20 | -0.01 | -0.13 | - |
| EPS (Diluted) | -0.24 | -0.09 | -0.13 | - |
| Free Cash Flow | -10.72 | -7.73 | -2.27 | -2.15 |
| Free Cash Flow Per Share | -0.14 | -0.11 | -0.06 | - |
| EBIT | -13.07 | -5.26 | -3.09 | -2.92 |
Source: S&P Capital IQ. Standard template.
Financial Sources.